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A B S T R A C T   
Background: Recently, there has been a growing interest in mucointegration as the formation of an early and 
long-standing soft tissue barrier seems essential for both the initial healing and long-term implant survival. 
Aim: To develop an experimental method to characterize the mucointegration of different transgingival materials 
(titanium (Ti), polyetheretherketone (PEEK), polymethylmethacrylate (PMMA), zirconia (Zi), polymer infiltrated 
ceramic network (PICN), cobalt-chrome (Co–Cr), and lithium disilicate (LD)) in a human model. 
Methods: The study is designed as a multi-part randomized controlled clinical trial. Ninety bone level Straumann 
implants will randomly receive an experimental, custom-made abutment to allow for the removal of the abut-
ment together with the surrounding soft tissues using a punch biopsy device at 8 weeks of healing (10 per 
material). The specimens will be further processed for non-decalcified histology, followed by histomorphometric 
analysis. The same protocol will be used for additional 90 implants-abutments, but during harvesting, soft tissues 
will be separated from the abutment and processed for immunohistochemistry in order to study tissue inflam-
mation and vascularization, while the abutments will undergo SEM analysis. Additionally, in vitro analyses, 
including SEM and profilometry, will be performed in order to characterize surface topography of all experi-
mental materials. 
Conclusion: The limited number of pilot samples presented herein indicate that the use of custom-made abut-
ments in humans is a reproducible method to study peri-implant soft tissue integration. This further intensifies 
the rationale to compare different abutment materials, used as transgingival components in daily practice, under 
the same conditions.   
1. Introduction 
Osseointegration used to be the main concern regarding dental 
implant integration during the last decades [1–4]. As osseointegration 
can be successfully achieved with various implant systems nowadays, 
the interest has slowly shifted towards peri-implant soft tissue integra-
tion, i.e., mucointegration [5]. Indeed, the formation of an early and 
long-standing soft tissue barrier seems essential for both the initial 
healing and long-term implant survival [6–8]. Soft tissue-friendly 
prosthodontics have been deemed necessary in order to avoid 
breakdown in the equilibrium that could lead to bacterial penetration, 
and consequently to peri-implant disease or even implant loss. 
The findings from both in vitro and in vivo studies have suggested that 
physico-chemical material characteristics of the abutment may signifi-
cantly influence the integration of the peri-implant soft tissues [9]. It 
was previously reported that abutment surface properties influence the 
adhesion, proliferation, and colonization of both cells and microorgan-
isms [10], and are, therefore, considered the key influencing factors of a 
stable and healthy transmucosal seal. Although titanium has been the 
material of choice for abutments due to its biocompatibility and 
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predictability demonstrated in many clinical studies and reviews 
[11–13], titanium-free abutmnents have been gaining popularity lately. 
With the invention and use of other more esthetic materials, as well as 
the esthetic expectations of the patients that have become clearly higher 
through the years [14], and their requests for faster treatments, there is a 
clear need to compare the existing materials in terms of its effects on 
both hard and soft peri-implant tissues. Consequently, many different 
materials are used as supragingival components that come in contact 
with the soft tissues around restored implants, either for immediate 
loading with provisionals crowns or for the definitive prosthodontic 
restorations. 
Although valuable insights about several materials used supra-
gingivally have been obtained from both in vitro and preclinical in vivo 
studies [15–23], considerable limitations inherent to these type of 
studies make the extrapolations of the results to a clinical setting diffi-
cult and rather unpredictable. However, there is limited clinical data 
comparing peri-implant soft tissue integration of the existing restorative 
materials and materials used for implant abutments. One of the first 
human studies reported that the peri-implant soft tissue formed at the 
experimental titanium one-piece mini-implants was of a character 
similar to that described in animal studies [24]. Similar findings were 
obtained by Tomasi et al. [11], who reported on the dimensional and 
qualitative characteristics of the mucosa around titanium abutments. 
Additional studies compared titanium and zirconia abutments [10,25, 
26] or titanium and PEEK abutments [27] in human, although histo-
logical assessment of healing was not always performed. There is little 
clinical data regarding other materials frequently used in daily practice 
for provisional crowns for immediate loading at implant placement, 
such as polymethylmethacrylate, for instance. Overall, the robust ran-
domized control trials that could compare the bulk of the materials used 
by practitioners nowadays, in a proper clinical setting and under the 
same conditions, are still missing. 
This project aims to develop the protocol to characterize the mucosal 
integration of seven different abutment materials (titanium (Ti), poly-
methylmethacrylate (PMMA), polyetheretherketone (PEEK), zirconia 
(Zi), cobalt-chrome (Co–Cr), and lithium disilicate (LD) in a human 
model. Additionally, Zi abutments with three different surface rough-
ness will be tested. 
In order to validate the experimental method and the sample size, a 
pilot study using titanium abutments was initially conducted. 
2. Methods/design 
2.1. Study design 
The overall project will encompass 3 distinct, stand-alone random-
ized controlled clinical trials (Part I, II, III), which will be based on the 
same study design (explained further below; Table 1), but will involve 
different abutment materials: 
PART I  
1 Ti Grade 4  
2 PMMA (Multilayer shaded PMMA discs, Dentsply Sirona, York, PA, 
USA)  
3 PEEK (breCAM.BioHPP, Bredent, Senden, Germany) 
PART II  
1 Zi – machined - as delivered by the manufacturer (0.2 μm)  
2 Zi – ultra-polished surface (0.05 μm)  
3 Zi – rough surface (0.5–1 μm) 
PART III  
1 PICN  
2 Co–Cr  
3 LD 
Each of these parts will include one preclinical study and 2 RCTs: 
2.1.1. Raw abutment characterization – preclinical study 
The surface topography of all materials to be used in the present 
project will be characterized using scanning electron microscopy (SEM) 
and profilometry. 
The same study protocol will be used for PART I, PART II, and PART 
III. 
2.1.2. Non-decalcified histology – RCT 
The custom-made experimental abutments will be used to allow for 
the removal of the abutment together with the surrounding soft tissues 
using a punch biopsy device at 8 weeks of healing. The specimens will be 
further processed for non-decalcified histology. Additional TEM analysis 
will be performed for PEEK samples. 
The same study protocol will be used for PART I, PART II, and PART 
III. 
Table 1 
Overall project & sample distribution. 
Ti – titanium; PMMA – polymethylmethacrylate; PEEK – polyetheretherketone; Zi – zirconia; PICN – polymer infiltrated ceramic network; Co-Cr – cobalt- 
chrome; LD – lithium disilicate; TEM – transmission electron microscopy; SEM – scanning electron microscopy; IHC – immunohistochemistry. 
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2.1.3. SEM/immunohistochemistry – RCT 
The custom-made experimental abutments will be retrieved using 
punch biopsy device, but soft tissues will be separated from the abut-
ment in order to evaluate the cell adhesion on the abutment surface 
using SEM, while the surrounding tissues will be processed for immu-
nohistochemistry (IHC) in order to study proinflammatory markers. 
The same study protocol will be used for PART I, PART II, and PART 
III. 
Patient inclusion will be performed in 2 centers: University Hospital 
Liège, Liège, Belgium (for PARTS I, II, and III) and a private clinic “Dr. 
Happe und Kollegen”, Münster, Germany (for PART II). Overall, 180 
participants will be enrolled (that is, 30 per each RCT and since each 
study PART contains 2 RCTs, 60 participants will be enrolled for each 
study PART; Table 1). 
2.2. Study protocol 
2.2.1. Raw abutment characterization 
In vitro characterization of materials used for abutments will include 
evaluation of surface characteristics using SEM and Profilometry. A total 
of 27 samples will be characterized (9 per each study PART; Table 1). 
2.2.1.1. SEM. The surface morphology of the abutments will be eval-
uated using an analytical benchtop scanning electron microscope 
(TM3030, Hitachi High-Technologies Europe GmbH, Krefeld, Ger-
many). The samples will be mounted on aluminium stubs with 
conductive carbon tape and images will be taken with an accelerating 
voltage of 15 kV. Prior to imaging, the polymeric samples, such as PEEK 
and PMMA, will be sputter-coated with gold (Cressington 108 Auto, 
Cressington Scientific Instruments, Watford, UK). The images obtained 
will serve to describe materials’ external morphology (texture) as well as 
the cleanness of a surface. 
2.2.1.2. Profilometry. Profilometry measurements will be performed on 
an S Neox optical profiler from Sensofar (Spain) controlled with the 
SensoSCAN 6.3 software, also from Sensofar. Samples will be imaged 
with an EPI 50× objective using the confocal mode at six random non- 
overlapping positions with an area of 350.88 Å~ 264.19 μm2 (1360 
px Å~ 1024 px). Surface parameters will be obtained from image 
analysis and processing will be done using SensoMap Standard 7.3 
(Sensofar, Digital Surf’s Mountains Technology®, Spain). 
2.2.2. Non-decalcified histology – RCT 
2.2.2.1. RCT – study design. Thirty implants will be randomly allocated 
to one of the 3 experimental materials. Therefore, 10 abutments per 
condition will be available for further analyses. 
2.2.2.2. Randomization. Experimental abutments will be randomly 
allocated so that no more than two different abutment materials are 
placed in the same patient. Randomization will be performed using a 
table containing multiple lines of random presets of six combinations in 
each line, formed with letters A, B, and C pertaining to the three 
different experimental abutments (e.g. B, BC, AC, A, C, AB, etc.), taking 
into account that a patient may receive more than one implant/abut-
ment. For instance, if a patient were to receive one implant, based on the 
above example, he/she will 
Receive abutment B; the next patient receiving one implant would 
receive abutment A; the next patient receiving two implants will receive 
abutments B&C, etc. 
2.2.2.3. Inclusion criteria.  
• Participants have to voluntarily sign the informed consent form 
before any study related action   
• Patients aged 18 or over   
• Patients with one or more missing teeth in the maxillary or mandible 
area, seeking implant therapy   
• Men/women   
• Patients in good systemic health (ASA I/II) and no contraindication 
for oral surgical interventions   
• Patients requiring a replacement of missing teeth; the tooth at the 
implant site(s) must have been extracted or lost at least 12 weeks 
before the date of implantation   
• At least 3 mm of fibrous mucosa in the bucco-lingual dimension   
• Full mouth plaque score (FMPI) lower than or equal to 25%   
• At least a diameter of 4 mm for the implant (regular d diameter) 
2.2.2.4. Exclusion criteria.  
• Autoimmune disease requiring medical treatment   
• Medical conditions requiring prolonged use of steroids   
• Use of Bisphosphonates intravenously or more than 3 years of oral 
use   
• Infection (local or systemic) – patients with gingivitis or active local 
infection will undergo a medical treatment prior to the entrance to 
the study, and each individual will be evaluated for suitability; in 
case of a systemic infection, the evaluation will be based on medical 
anamneses, and if necessary, a patient will be referred to relevant 
medical tests   
• Current pregnancy or breastfeeding women   
• Alcoholism or chronical drug abuse   
• Immunocompromised patients   
• Uncontrolled diabetes   
• Smokers   
• Prisoners   
• Implant’s diameter under 4 mm (narrow implant)   
• Conditions or circumstances, in the opinion of the investigator, 
which would prevent completion of the study or interference with 
analysis of study results, such as history of non-compliance, or 
unreliability 
2.2.2.5. Local exclusion criteria.  
• Sites treated with socket preservation techniques   
• Untreated local inflammation  
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• Mucosal diseases or oral lesions   
• History of local irradiation therapy in head-neck area   
• Persistent intraoral infection   
• Patients with bad oral hygiene   
• Patients unmotivated for standard home-care 
2.2.2.6. Materials.  
• Implants 
Regular Bone Level or Bone Level Tapered Implants featuring the 
CrossFit® connection (4.1 or 4.8 mm) will be used in the study (Strau-
mann®, Straumann, Basel, Switzerland).  
• Abutment materials 
The CAD/CAM experimental abutments will be used as delivered by 
the manufacturer without any further surface modifications in the PART 
I and PART III of the project; in the PART II, Zi abutments will undergo 
in-lab surface modifications in order to achieve different surface 
roughness. 
A dental manufacturing company ProScan (Zonhoven, Belgium) will 
produce the abutments using the above mentioned materials. A custom- 
made abutment design has been developed in order to allow sample 
harvesting using a guide that is screwed on the top of the experimental 
abutment at the time of the abutment retrieval (the retrieval of the 
abutment together with the ring of soft tissues attached to its surface in 
one bloc using punch biopsy) (Fig. 1). In cases when the material does 
not allow full abutments to be produced, Ti will be used as a base and the 
material will be used as a ‘sleeve’ that comes in contact with the soft 
tissues, as illustrated in Fig. 1d.  
• Punch device 
A circular punch device (Acu-Punch, Acuderm inc., Milan, Italy), 4 
mm wide, will be forced apically so that it encompasses the punch guide 
of 3.8 mm in order to harvest the tissues surrounding the experimental 
abutment. 
2.2.2.7. Screening and consent. Prospective participants will be 
screened for enrolment in the study according to the criteria listed 
above. Only participants that comply with the inclusion criteria will be 
enrolled in the study. Potential participants at each study site will be 
provided with written information concerning the study, explaining the 
study requirements, and possible risks. Study coordinators/investigators 
will ensure that potential participants understand the information pro-
vided, and will review requirements and potential risks. 
Individuals agreeing to participate in the study will have to sign the 
informed consent form according to local regulations. All signed consent 
forms will be maintained in the investigator’s file at the study site. 
During the screening visit, patients will be examined clinically and 
they will undergo a cone beam CT scan with a cotton roll on the buccal 
side in order to be able to evaluate the buccal soft tissues thickness, to 
assess the bone dimensions in the area of interest, and to assure that they 
comply with the requirements of at least 6 mm in width (the bucco- 
lingual dimension) and at least 8 mm in height (the apico-coronal 
dimension). This is a routine test for patients seeking dental implant 
therapy. Previous bone regeneration, except sinus lift, is one of exclusion 
criteria. 
The approval of the institutional Ethical Committee has already been 
obtained for PART I (B707201628072). All RCTs will be registered at 
ClinicalTrials.gov (https://clinicaltrials.gov). 
2.2.2.8. Surgical procedure. All subjects will receive preoperative anti-
biotic (amoxicillin 2 g, or if allergic, clindamycin 600 mg). After local 
anaesthesia, if necessary, a crestal incision will be made above the 
treatment site, and mucoperiostal flaps will be reflected to allow access 
to the site. Alternatively, a punch biopsy and a flapless approach for 
implant placement can be considered; the flap design decision-making 
will be entrusted to the surgeons. 
The implantation procedure will be carried out according to a stan-
dard surgical protocol, and according to the manufacturer’s protocol. All 
implants will have to reach an insertion torque higher than 15 Ncm. 
Implants will be randomly assigned to one of the study groups after flap 
opening. The abutment will be placed in a non-submerged approach and 
tightened at 10 N/cm for a period of 8 weeks in total. The mucoper-
iosteal flaps will be sutured with non-resorbable interrupted sutures. 
The abutment screw access channel will be closed with a layer of Teflon 
tape to isolate the screw head from the composite used to seal the access 
channel (Telio, Ivoclar Vivadent, Ellwangen, Germany) (Fig. 2). 
A standard periapical x-ray will be taken, in order to index the level 
of the implant in the apico-coronal direction. The patients will be 
instructed to rinse twice daily with an aqueous solution of 0.2% chlor-
hexidine. In addition, analgesics (ibuprofen 400 mg, up to 4/d) will be 
prescribed for the following days according to individual needs. Patients 
will be also instructed to refrain from mechanical plaque removal in the 
area of implantation for 1 week. The sutures will be removed after 10–14 
days. After suture removal, they will stop using mouthwashes and will 
be instructed to apply standard hygiene procedures. 
2.2.2.9. Harvesting procedure. The specimens will be retrieved 8 weeks 
after implant placement, following local anaesthesia. The abutments 
Fig. 1. A custom-made abutment design (a); a custom-made titanium abutment (b), PEEK abutment (c), and a custom-made zirconia abutment: zirconia ‘sleeve’ on a 
Ti base. 
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will be replaced by an SRA abutment (Straumann®, Straumann, Basel, 
Switzerland). During the removing procedure, a custom-made guide and 
then a punch biopsy device will be used to retrieve a circumferential 
biopsy so that peri-implant soft tissues around the abutment are har-
vested together with the abutment (Fig. 3). 
2.2.2.10. Data collection. The following clinical measurements will be 
taken at the time of abutment connection and at follow-ups:  
- Keratinized tissue height buccally and lingually – from the most 
apical point of the gingival margin to the mucogingival junction at 
the mid-buccal point (using a periodontal probe);  
- Soft tissue thickness above the bone crest;  
- Periodontal biotype at natural adjacent teeth (according to De Rouck 
et al. [28]);  
- Peri-implant plaque index (PI);  
- Presence of suppuration and any adverse events will be noted. 
Clinical photography and intra-oral radiographs using the parallel 
technique will be taken at the time of the experimental abutment 
removal at 8-week follow-up. 
2.2.2.11. Histology. The samples retrieved with a punch biopsy and 
containing the abutment and the surrounding soft tissue will be 
processed for non-decalcified histology using polymethacrylate 
(PMMA). Briefly, after fixation for 2 days in a 4% formaldehyde solu-
tion, the samples will be dehydrated in graded series of ethanol followed 
by xylene. Thereafter, the samples will be embedded in poly-
methylmethacrylate (Merck). The resulting resin blocks will be cut 
vertically parallel to the abutment axis with a diamond-coated saw (VC- 
50, Leco) in a mesio-distal direction and once again in a bucco-oral di-
rection. The sections will be ground to a final thickness of 150 μm 
(Pedemax-2, Struers) and stained with Toluidin Blue-Fuchsin. The sec-
tions will be scanned at high resolution with a Zeiss microscope (Axio 
Imager. M2, Zeiss). 
2.2.2.12. Histomorphometry. These digital images are used to locate 
anatomical landmarks. Histometric measurements to determine the di-
mensions of the biological width (i.e. vertical distances of sulcus depth, 
epithelial component and soft connective tissue component) will be 
carried out by using an image analysis software (ZEN pro 2012, Zeiss). 
2.2.2.13. Transmission electron microscopy (TEM). The specimens will 
be infiltrated with resin and 70 nm ultrathin sections will be cut with 
diamond knives mounted on a Leica EM UC6 microtome. The sections 
will be cut through the intact interface between PEEK abutments and the 
peri-implant soft tissues. The sections will be examined in a Supra 40 VP 
SEM equipped with a TEM detector at magnification ×1′000 to 200′000. 
Fig. 2. Intra-operative images: surgical site (a), implant bed preparation (b), implant placement (c), custom-made abutment placement (d), suturing (e), closing of 
abutment screw access channel (f). 
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The images obtained will serve to describe the adherence mechanisms of 
both the junctional epithelium and the peri-implant connective tissue to 
the abutment surfaces. 
2.2.3. SEM/immunohistochemistry – RCT 
2.2.3.1. RCT – study design. Thirty implants will be randomly allocated 
to one of the 3 experimental materials. Therefore, 10 abutments per 
condition will be available for further analyses. 
The same surgical protocol as described for B| Non-decalcified his-
tology will be applied up to the harvesting procedure. 
2.2.3.2. Harvesting procedure. Once the experimental abutment is 
retrieved using the punch device, the tissue biopsy will be detached from 
the abutment by pulling the ring out with a micro tweezer instrument. 
The biopsy will be subjected to immunochemistry (IHC). Additionally, 
the experimental abutment will be subjected to SEM in order to evaluate 
the cell adhesion on the abutment surface (Fig. 4). 
2.2.3.3. SEM analysis. The abutments will be fixed in a 2.5% glutaral-
dehyde in distilled water during 1–2 h at 0–4◦c. Thereafter, the samples 
will be rinsed with distilled water during 10–20 min at 0–4 ◦C. A second 
fixation will be performed with 1–4% osmium tetroxide in distilled 
water during 1–2 h at 0–4 ◦C. Thereafter, the samples will be rinsed with 
distilled water during 10–20 min at 0–4 ◦C and then dehydrated during 
10 min in crescent ethanol bath (25%, 50%, 70–75%, 90–95%, 100%) at 
0–4 ◦C. For the analysis, the abutments will be mounted on specimen 
stub with silver paste and coated with gold/palladium alloy. A quali-
tative analysis will be performed, and if possible, an evaluation of the 
percentage of surface covered with cells will be performed. 
2.2.3.4. IHC analysis. The soft tissue samples will be immediately fixed 
in a PLP solution (0.01 M periodate, 0.75 M Lysine, 2% para-
formaldehyde) (McLean & Nakane, 1974, Rosendren et al., 1994) for 3 h 
at room temperature. Thereafter, the samples will be rinsed in 10% 
sucrose-phosphate-buffered saline overnight. Fixed soft tissue biopsies 
will be embedded and frozen in 2-methylbutane in liquid nitrogen and 
stored at − 70 ◦C until sectioning. Frozen sections will be cut and fixed in 
cold acetone and stored at − 70 ◦C. Endogenous peroxidase activity will 
be blocked by incubation with 0.3% H2O2. The immunoincubation will 
be performed with the following antibodies:  
• CD3: T-cells  
• CD20: B-cells  
• CD68: monocytes/macrophages  
• CD34: blood vessels 
All sections will be analysed with light microscopy (×2, ×16, ×40, 
×100; Olympus IX 81 Shinjuku, Tokyo, Japan) in order to locate the 
inflammatory cells present and blood vessels. Each antibody will be 
assessed in each soft tissue sample and will be categorized following this 
classification: 
Fig. 3. a. Harvesting procedure (occlusal view): a custom-made abutment in place (a); a custommade guide corresponding to the diameter of the punch device is 
screwed on the experimental abutment in order to facilitate the harvesting procedure (b); tissues after using a punch biopsy device (c); SRA abutment (d) and 
protecting cap in place (e). 
Fig. 4. Soft tissues and the experimental abutment will be separated and sub-
jected to IHC and SEM, respectively. 
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(− ) no labelled cells. 
(+) a few labelled cells. 
(++) a focal infiltration of labelled cells. 
(+++) an intense infiltration of labelled cells throughout the tissue. 
2.2.4. Statistical methods 
Power analyses has been performed to define the population sample. 
Descriptive statistics will be performed using means of absolute and 
relative frequency and medians and means. The analysis of the outcome 
measures will be performed using appropriate statistical tests according 
to the distribution patterns. The calculation will be performed using SAS 
(version 9.3 for Windows). 
3. Results of the pilot study (titanium abutments) 
3.1. Raw abutment characterization 
3.1.1. SEM 
The regular pattern produced by the machining process could be 
observed in the titanium abutments (Fig. 5). 
3.1.2. Profilometry 
The results obtained for amplitude parameters like root-mean-square 
deviation, (Sq) skewness (Ssk), and kurtosis (Sku), and hybrid parame-
ters such as the density of summits (Sds) and the developed interfacial 
area ratio (Sdr) are presented. Additionally, we also present a set of 
functional indices like the core fluid retention, Sci, the surface bearing 
index, Sbi, and the valley fluid retention, Svk in order to clarify the 
possible correlation between the surface properties of the abutments and 
tissue integration. 
All results were obtained from the measurements performed at six 
randomly distributed spots on three different abutments (N = 18) and 
the values are presented as the mean ± SD (Table 2a,b,c). 
3D reconstruction was also performed in order to demonstrate the 
specific topography and surface characteristics of the experimental 
abutment (Fig. 6). 
3.2. Non-decalcified histology & SEM/immunohistochemistry 
3.2.1. Demographics and site-related data 
All patients were included at the Department of Periodontology and 
Oral Surgery, Faculty of Medicine, University of Liège, Belgium. Nine 
patients were included in this pilot study; 4 (44.4%) were females and 5 
(55.6%) were males, with a mean age of 58.8 years (range: 35–77 years). 
None of the participants were smokers (Table 3). 
A total of 10 implants were inserted into the surgical sites, out of 
which 8 in the premolar position. Regarding flap design, none of the 
implants were placed using a flapless approach. Bone quality was type 2 
or 3 in all but one case. All inserted implants had a diameter of 4.1 mm 
and although the length varied, the minimum was 8 mm (Table 4). 
Similar values were recorded preoperatively and postoperatively for 
both keratinized tissue height (buccally and lingually) and soft tissue 
thickness above the bone crest, and no statistically significant differ-
ences were found (Table 5). 
Fig. 5. Representative SEM micrographs of titanium obtained with a 2.5 k magnification (a) and 10 k amplifications (b).  
Table 2a 
Amplitude parameters.  
Sq (μm) Ssk Sku 
0.49 ± 0.15 0.36 ± 0.27 2.54 ± 0.37 
Sq - root-mean-square deviation; Ssk – skewness; Sku – kurtosis. 
Table 2b 
Hybrid parameters.  
Sdr (%) Sds (μm− 2) 
2.06 ± 1.47 0.03 ± 0.01 
Sdr – interfacial area ratio; Sds – density of summits. 
Table 2c 
Functional indices.  
Sci Sbi Svi 
1.70 ± 0.14 0.54 ± 0.20 0.08 ± 0.01 
Sci – core fluid retention; Sbi – surface bearing index; Svk – valley fluid retention. 
Fig. 6. Representative profilometry image showing the 3D reconstruction ob-
tained for titanium. 
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3.3. Non-decalcified histology 
The interface between the abutment and the peri-implant soft tissues 
was characterized by a well-defined barrier epithelium coronally and a 
connective tissue apically to the junctional epithelium (Fig. 7); in a few 
cases, epithelial adhesion continued until the implant neck. Regarding 
the dimensions of these mucosal components, the following assessments 
were performed: sulcus depth, total mucosal height, epithelial adhesion 
length, and connective tissue adhesion length. The results are reported 
in Table 6. 
3.4. SEM/immunohistochemistry (IHC) 
3.4.1. SEM 
Overall, epithelial cells, connective tissue fibers, some erythrocytes, 
plaque, calculus, and inorganic compounds could be identified on SEM 
images (Fig. 8). The number of remaining cells differed from one abut-
ment to another, but some epithelial cells were found on all of them. The 
connective tissue fibers were found on the apical parts, but on a few 
abutments, the fibers were not found and the apical portion of the 
abutment was mainly acellular (only some inorganic particles were 
noted). The amount of plaque/calculus varied in quantity and it was 
localized mainly in the coronal parts of the abutments. 
3.4.2. IHC 
CD34-positive cells were found evenly distributed in connective 
tissue of all samples. An intense infiltration of HLA-DR-positive cells in 
the epithelium (Langerhans cells) was noted in all samples. On the other 
hand, only mild to moderate presence of inflammatory cells was 
observed in the connective tissue (Fig. 9). 
4. Discussion 
This study is designed to directly analyse, in a human model, 
different materials used as supragingival components in daily implant 
dentistry. Though a few clinical studies have attempted to test some of 
the materials used (mainly titanium and zirconia) [10,12,29], the main 
limitations of prior studies is that they focused on one or two materials 
and/or the study design was not a randomized clinical trial and/or the 
analyses performed did not allow for the direct observation of the 
interface between the abutment material and soft tissues (i.e. instead of 
histology, other surrogate outcomes have been used). The method and 
Table 3 
Characteristics of the study participants.    
Number of subjects 9 
Number of implants 10 
Mean age of subjects (range) 58.8 ± 15.3 (35–77) 
Gender (M/F) 5/4 
Smokers (yes/no) 0/9  
Table 4 
Patient and site-related characteristics.   
N/% 
Number of implants 10 
Implant position 
1st premolar 3 (30.0) 
2nd premolar 5 (50.0) 
1st molar 2 (20.0) 
Flap design 
Flap 10 (100.0) 
Flapless 0 (0.0) 
Bone quality 
1 0 (0.0) 
2 3 (30.0) 
3 6 (60.0) 
4 1 (10.0) 
Implant length (mm) 
8 6 (60.0) 
10 3 (30.0) 
12 1 (10.0) 
Implant diameter (mm) 
4.1 10 (100.0)  
Table 5 
Soft tissue - clinical measurements.   
Surgery Abutment removal (8 w) 
Keratinized tissue height 
Buccal 3.2 ± 0.6 [2–4] 3.4 ± 0.5 [3–5] 
Lingual 5.9 ± 2.7 [3–12] 6.0 ± 3.3 [3–14] 
Soft tissue thickness 4.3 ± 2.3 [3–7] 4.3 ± 2.3 [3–7]  
Fig. 7. Non-decalcified histology: soft tissue adhesion on the surface of the abutment harvested and processed together (a); clearly distinguishable epithelial and 
connective tissue (b): measurements include sulcus depth (SD), epithelial (JE) and connective adhesion length (CT); higher magnification (c). 
Table 6 
Results from the histometric linear measurements.   
Mean SD Min Q1 Median Q3 Max 
Sulcus 0.61 0.44 0.07 0.25 0.56 0.88 1.38 
Epithelium 2.68 0.96 1.00 2.21 2.60 3.23 4.06 
Conn. tissue 1.06 0.94 0.00 0.09 1.12 1.71 2.46 
Data are presented in mm. 
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design described herein is unique in that it aims to evaluate all major 
materials used for supragingival components in a clinical setting under 
the strict conditions of an RCT. Moreover, the analyses planned are 
aiming to encompass several different aspects, from the abutment in 
vitro characterization to the assessment of healing outcomes through 
histology and direct visualization of the abutment-soft tissue interface, 
and further soft tissue characterization in terms of inflammation and 
vascularization. 
Preclinical raw abutment characterization has been added to the 
planned clinical studies as previous studies have demonstrated that the 
roughness of surface influenced the cellular adhesion and the shape of 
cells, sich as gingival fibroblasts [30]. Smoother surface are also 
considered to be less prone to bacterial adhesion and a surface roughness 
threshold of 0,4 μm was found to be favorable for microbial adhesion 
[9]. As the material used for abutment components may influence the 
adhesion and colonization of microbial species [31], profilometry and 
SEM analyses planned herein, performed for each material used, will 
allow for both surface characterization and comparison between the 
materials. 
Non-decalcified histology and the subsequent histomorphometric 
analyses will allow the assessment of soft tissue dimensions and peri- 
implant soft tissue barrier. The same protocol and study designs en-
sures that the main influence on biological width and abutment-soft 
tissue interface will be that of the abutment material applied, which 
will allow inter-material comparison. Our pilot results on titanium 
abutments, which demonstrated a longer junctional epithelial and 
shorter connective tissue length, are in accordance with several previous 
studies [10,24,32]. However, several other materials have not been 
assessed previously in this regard and this study will provide much 
needed information relative to their potential to ensure an adequate 
mucosal attachment. 
Immunohistochemical analyses will be performed to assess the level 
of soft tissue inflammation and cellular and vascular densities in the soft 
tissue surrounding the abutments. Tomasi et al. [12] reported on the 
tissue interactions with titanium surface, but again, the comparison 
between the different materials is missing in the literature and this study 
has a potential to provide some additional insights in this regard. 
The present pilot study provided valuable information in regards to 
optimal main study design and the following final sample size calcula-
tion, namely the need to separate initially planned single RCT into two 
RCTs and the subsequent doubling of number of subjects that need to be 
enrolled in each study for adequate power, using the length of biological 
width/epithelium and the percentage of positive cell markers as primary 
endpoints for the first and second RCT, respectively. 
Our preliminary results from a pilot study on titanium abutments 
indicate that the methods described herein—from abutment design to its 
removal—render all planned analyses feasible. Experimental abutment 
failure was not observed and it was demonstrated that it could be suc-
cessfully used for soft tissue sampling. Surgical parts of the protocol as 
well as the follow-ups were uneventful and the harvesting method, with 
the use of a custom-made guide over the experimental abutment, was 
straightforward, reliable, and reproducible. Furthermore, the proposed 
approach is minimally invasive for patients as the experimental abut-
ment of a small diameter had been specifically designed to allow for a 
punch biopsy to be taken and soft tissues to heal properly thereafter. 
Therefore, the healing is not hampered by this procedure and, at the 
same time, the harvested specimens allow for the interface between the 
experimental abutment and soft tissues to be directly assessed and 
analysed. 
A few obstacles encountered during the pilot study were mostly of 
technical nature and were easily overcome; however, the use of HLA-DR 
antibody did not prove to be of adequate value as it was not possible to 
Fig. 8. Representative SEM micrograph of titanium abutment obtained after soft tissue removal from the abutment, showing soft tissue remnants on the surface of 
the abutment (a & b); on higher magnifications, the presence of epithelial cells (c) and connective tissue (d) could be observed. 
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perform a quantitative analysis in the samples in which HLA-DR marker 
was used. Additionally, HLA-DR is not a highly specific marker and it has 
been therefore decided to exclude this marker from further analyses and 
to instead use separate markers for different cell types in the main study 
(as explained in the present Methods/Design section), so that the pres-
ence of different cells in the connective tissues can be quantified. 
Overall, the pilot study helped us validate the study design and fine- 
tune the protocols used. 
One of the limitations of the present study is that it focuses on early 
stages of healing and due to the already substantially complex and 
challenging study design, different time points were not considered. The 
present time point was chosen based on other clinical studies which 
reported the formation of mature tissue at 8 weeks of peri-implant soft 
tissue healing [32,33]. 
The ultimate goal of this study is to provide more information on the 
effects of different materials on peri-implant soft tissue integration, 
which would be helpful in daily decision-making when it comes to 
chosing the optimal material(s) for either provisional crowns or defini-
tive restorations. Helping practitioners make good choices at this stage 
will likely have influence not only on initial healing, but also on long- 
term implant survival. 
Fig. 9. Histological (HE; a, b, c) and immunohistochemical images (CD34 – d, e, f; HLA-DR – g, h, i). Horizontally, axial sections (a, d, g), transversal sections (b, e, 
h), and high magnification sections (c, f, i) are shown. Both epithelial and connective tissue can be observed in all images. 
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5. Conclusion 
The preliminary results on titanium abutments, based on the study 
protocol presented herein, show that the usage of custom-made abut-
ments in human model is a reproducible method to study peri-implant 
soft tissue integration. This further intensifies the rationale to compare 
different abutment materials used in daily practice under the same 
conditions. 
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